QPCTL Antibodies

Santa Cruz Biotechnology offers a broad range of QPCTL Antibodies for investigating QPCTL protein function. QPCTL Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). QPCTL, or glutaminyl cyclase, is an enzyme responsible for post-translational modification of proteins, specifically in forming pyroglutamate residues. This modification maintains stability and activity of numerous neuropeptides and hormones, which influence various physiological processes. QPCTL research has significant implications for understanding neurodegenerative diseases and other pathological conditions. Monoclonal QPCTL antibodies enable precise detection and characterization of QPCTL expression patterns across different tissues and cellular compartments. Researchers can track QPCTL localization and examine its interactions with other molecular components. Advanced imaging techniques combined with QPCTL monoclonal antibodies reveal detailed insights about cellular distribution and trafficking. Santa Cruz Biotechnology monoclonal QPCTL antibodies support researchers worldwide in advancing scientific knowledge about neurodegenerative disorders and protein modification pathways.